XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
TOTAL REVENUE $ 12,054 $ 10,790 $ 29,801 $ 43,403
COST OF GOODS SOLD [1] (3,703) (2,868) (13,201) (8,121)
RESEARCH AND DEVELOPMENT EXPENSES [2] (7,282) (7,688) (22,093) (27,214)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [3] (2,954) (2,816) (9,263) (8,197)
OPERATING LOSS (1,885) (2,582) (14,756) (129)
FINANCIAL EXPENSES (2,410) (1,973) (6,613) (7,150)
FINANCIAL INCOME 96 118 403 359
FINANCIAL EXPENSES - NET (2,314) (1,855) (6,210) (6,791)
OTHER INCOME     51  
NET LOSS FOR THE PERIOD $ (4,199) $ (4,437) $ (20,915) $ (6,920)
LOSS PER SHARE OF COMMON STOCK - BASIC $ (0.09) $ (0.14) $ (0.48) $ (0.25)
LOSS PER SHARE OF COMMON STOCK - DILUTED $ (0.09) $ (0.14) $ (0.48) $ (0.25)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC 45,556,647 32,863,788 43,761,769 27,758,104
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED 45,556,647 32,863,788 43,761,769 27,758,104
Goods [Member]        
TOTAL REVENUE $ 4,506 $ 3,296 $ 12,260 $ 11,975
License and R&D Services [Member]        
TOTAL REVENUE $ 7,548 $ 7,494 $ 17,541 $ 31,428
[1] (1) Includes share-based compensation
[2] (2) Includes share-based compensation
[3] (3) Includes share-based compensation